Cytochalasin E
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cytochalasin E
Description :
Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. Cytochalasin E is a potent actin depolymerization agent, and it binds and caps the barbed end of actin filaments to prevent actin elongation[1][2].UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
AutophagyType :
Natural ProductsRelated Pathways :
AutophagyApplications :
COVID-19-immunoregulationField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/cytochalasin-e.htmlPurity :
99.90Solubility :
DMSO : 50 mg/mL (ultrasonic; warming)Smiles :
O=C1[C@]2(O3)[C@]([C@@H]([C@](O4)(C)[C@@H]4[C@]2([H])/C=C/C[C@@H](C([C@](C)(O)/C=C/OC3=O)=O)C)C)([H])[C@H](CC5=CC=CC=C5)N1Molecular Formula :
C28H33NO7Molecular Weight :
495.56Precautions :
H302, H315, H319, H335References & Citations :
[1]Udagawa T, et al. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesisand tumor growth. J Pharmacol Exp Ther. 2000 Aug;294 (2) :421-7.|[2]Lu QY, et al. Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenicmodel. Clin Cancer Res. 2005 Feb 15;11 (4) :1675-83.|[3]Takanezawa Y, et al. Variation in the activity of distinct cytochalasins as autophagy inhibitiors in human lung A549 cells. Biochem Biophys Res Commun. 2017 Dec 16;494 (3-4) :641-647.Shipping Conditions :
Blue IceStorage Conditions :
-20°C, 3 years (Powder)Scientific Category :
Natural ProductsClinical Information :
No Development ReportedCAS Number :
[36011-19-5]

